Page last updated: 2024-08-20

dextrothyroxine and Intestinal Pseudo-Obstruction

dextrothyroxine has been researched along with Intestinal Pseudo-Obstruction in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alrabaa, S; Casanas, B; Jariwala, R; Kapadia, S; Restrepo-Jaramillo, R; Sriaroon, C; Zeitler, K1
Adhikari, S; Duflou, J; Konecny, P; Marjoniemi, V; McWhinney, B; Pretorius, CJ; Weatherall, CJ1
Abrams, H; Bogoch, II; Fleckenstein, L; Keystone, JS; Khan, K; Leung, E; Nott, C1
Lucey, DR; Miele, PS; Neva, FA; Peregoy, KS; Smith, MA; Tarr, PE1
Endo, H; Ishikawa, A; Kondo, H; Nakamura, T; Tanaka, S; Yoshida, H1

Reviews

1 review(s) available for dextrothyroxine and Intestinal Pseudo-Obstruction

ArticleYear
Recurrent paralytic ileus associated with strongyloidiasis in a patient with systemic lupus erythematosus.
    Modern rheumatology, 2006, Volume: 16, Issue:1

    Topics: Animals; Antiparasitic Agents; Female; Glucocorticoids; Humans; Immunocompromised Host; Intestinal Pseudo-Obstruction; Ivermectin; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Radiography; Recurrence; Strongyloides; Strongyloidiasis

2006

Other Studies

4 other study(ies) available for dextrothyroxine and Intestinal Pseudo-Obstruction

ArticleYear
Successful use of subcutaneous ivermectin for the treatment of
    BMJ case reports, 2018, Jun-04, Volume: 2018

    Topics: Adult; Animals; Asthma; Critical Illness; Dexamethasone; Drugs, Investigational; Female; Glucocorticoids; HIV Infections; Humans; Immunocompromised Host; Injections, Subcutaneous; Intestinal Diseases, Parasitic; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Ivermectin; Male; Strongyloides stercoralis; Strongyloidiasis

2018
Case Report: Subcutaneous Ivermectin Pharmacokinetics in Disseminated
    The American journal of tropical medicine and hygiene, 2018, Volume: 99, Issue:6

    Topics: Adult; Animals; Antiparasitic Agents; Autopsy; Diarrhea; Fatal Outcome; Hepatitis C; HIV Infections; Humans; Injections, Subcutaneous; Intestinal Pseudo-Obstruction; Ivermectin; Male; Strongyloides; Strongyloidiasis

2018
Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.
    The American journal of tropical medicine and hygiene, 2015, Volume: 93, Issue:1

    Topics: Administration, Rectal; Adult; Animals; Antiparasitic Agents; Female; Humans; Injections, Subcutaneous; Intestinal Pseudo-Obstruction; Ivermectin; Male; Middle Aged; Strongyloides stercoralis; Strongyloidiasis; Treatment Failure

2015
Case report: Rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome.
    The American journal of tropical medicine and hygiene, 2003, Volume: 68, Issue:4

    Topics: Administration, Rectal; Antinematodal Agents; Enema; Female; Humans; Immunocompromised Host; Intestinal Pseudo-Obstruction; Ivermectin; Middle Aged; Strongyloidiasis; Treatment Outcome

2003